본문 바로가기
KERD
논문KCI 등재

Trend in Measles Seroprevalence in the Western Pacific Region: A Systematic Review

최영준|Park Ji Won
대한소아감염학회 (The Korean Society of Pediatric Infectious Diseases)|2024.04|Pediatric Infection and Vaccine|제31권 제1호|pp. 1-11|DOI 10.14776/piv.2024.31.e10

4

조회

0

다운로드

0

인용

0

참고문헌

키워드

VaccinationVaccineSeroprevalenceMeasles

초록

Despite improvements in vaccine coverage, a resurgence of measles has been reported, especially in the infant and adult populations in recent years. We conducted a systematic review of seroprevalence studies conducted in the Western Pacific Region (WPR) to provide insights into seropositivity trends in different countries. This systematic review aimed to collect data from all available measles seroprevalence studies to characterize the differences in population immunity against measles in different countries. We searched the online databases PubMed and Embase to identify: 1) observational studies that investigated seroprevalence in all age groups, and 2) results reported as antibody levels. The following variables were extracted from different study arms: paper identification (title, first author, publication year), inclusion and exclusion criteria, study site, age of subjects, number of subjects, country/area, population, methods, and seropositivity (%). The search yielded a total of 69 studies included in the review. Among the 1–6-year-old group, seropositivity remained relatively high, at 81–100% in China, 86–94% in Korea, and 77–91% in Australia. In adolescents aged 7–18-years old, seropositivity was relatively constant in China and Australia over time; however, a decreasing trend was noted in Korea in 2011 (66%), 2014 (69%), and 2014 (50%) in this age group. A similar downward trend was observed among Korean adults aged 19–39 years in 2011 (74%), 2019 (71%), and 2019 (64%). Children are likely to be protected by universal vaccination programs in WPR countries and regions. However, susceptible individuals with waned immunity may be present among the adult population.

Abstract

Despite improvements in vaccine coverage, a resurgence of measles has been reported, especially in the infant and adult populations in recent years. We conducted a systematic review of seroprevalence studies conducted in the Western Pacific Region (WPR) to provide insights into seropositivity trends in different countries. This systematic review aimed to collect data from all available measles seroprevalence studies to characterize the differences in population immunity against measles in different countries. We searched the online databases PubMed and Embase to identify: 1) observational studies that investigated seroprevalence in all age groups, and 2) results reported as antibody levels. The following variables were extracted from different study arms: paper identification (title, first author, publication year), inclusion and exclusion criteria, study site, age of subjects, number of subjects, country/area, population, methods, and seropositivity (%). The search yielded a total of 69 studies included in the review. Among the 1–6-year-old group, seropositivity remained relatively high, at 81–100% in China, 86–94% in Korea, and 77–91% in Australia. In adolescents aged 7–18-years old, seropositivity was relatively constant in China and Australia over time; however, a decreasing trend was noted in Korea in 2011 (66%), 2014 (69%), and 2014 (50%) in this age group. A similar downward trend was observed among Korean adults aged 19–39 years in 2011 (74%), 2019 (71%), and 2019 (64%). Children are likely to be protected by universal vaccination programs in WPR countries and regions. However, susceptible individuals with waned immunity may be present among the adult population.

참고문헌 (81)

  1. Wang R, "Trends of the global, regional, and national incidence of measles, vaccine coverage, and risk factors in 204 countries from 1990 to 2019", Front Med(Lausanne), 8, pp.798031~ (2022)
  2. Gastañaduy PA, "Measles in the 21st century : progress toward achieving and sustaining elimination", J Infect Dis, 224(Suppl 2), pp.S420~S428 (2021)
  3. Hagan JE, "Progress toward measles elimination-Western Pacific Region, 2013–2017", MMWR Morb Mortal Wkly Rep, 67, pp.491~495 (2018)
  4. Cousins S, "Measles : a global resurgence", Lancet Infect Dis, 19, pp.362~363 (2019)
  5. Dimala CA, "Factors associated with measles resurgence in the United States in the post-elimination era", Sci Rep, 11, pp.51~ (2021)
  6. Leong WY, "Measles resurgence in Europe : migrants and travellers are not the main drivers", J Epidemiol Glob Health, 9, pp.294~299 (2019)
  7. Ammari LK, "Secondary measles vaccine failure in healthcare workers exposed to infected patients", Infect Control Hosp Epidemiol, 14, pp.81~86 (1993)
  8. Boulton ML, "A population profile of measles susceptibility in Tianjin, China", Vaccine, 34, pp.3037~3043 (2016)
  9. Chong KC, "Interpreting the transmissibility of measles in two different post periods of supplementary immunization activities in Hubei, China", Vaccine, 35, pp.1024~1029 (2017)
  10. Fu C, "Low measles seropositivity rate among children and young adults : a sero-epidemiological study in southern China in 2008", Vaccine, 28, pp.8219~8223 (2010)
  11. Han K, "The epidemiological and serological characteristics of measles in Dongguan, China, 2005–2014", Hum Vaccin Immunother, 12, pp.2181~2187 (2016)
  12. He H, "Waning immunity to measles in young adults and booster effects of revaccination in secondary school students", Vaccine, 31, pp.533~537 (2013)
  13. Liu Y, "Cross-sectional surveys of measles antibodies in the Jiangsu Province of China from 2008 to 2010 : the effect of high coverage with two doses of measles vaccine among children", PLoS One, 8, pp.e66771~ (2013)
  14. Liu Y, "Sero-epidemiology of measles in general population in Jiangsu province of China : application of mixture models to interpret the results from a cross-sectional study", Vaccine, 29, pp.1000~1004 (2011)
  15. Ma C, "Measles vaccine coverage estimates in an outbreak three years after the nation-wide campaign in China : implications for measles elimination, 2013", BMC Infect Dis, 15, pp.23~ (2015)
  16. Ma YJ, "Epidemiological investigation of measles in sera of healthy people in Heilongjiang Province, China", Jpn J Infect Dis, 64, pp.208~210 (2011)
  17. Pei L, "Identify the susceptibility profile to measles in the general population : Serological survey of measles antibodies in Shaanxi province, China, in 2016", Vaccine, 35, pp.7250~7255 (2017)
  18. Su X, "Dried blood spots : an evaluation of utility in the field", J Infect Public Health, 11, pp.373~376 (2018)
  19. Tang L, "Measles epidemics and seroepidemiology of population in Wujin, Changzhou city, Jiangsu province, China 2015", Vaccine, 35, pp.2925~2929 (2017)
  20. Wang X, "Seroprevalence of measles antibodies and predictors for seropositivity among Chinese Children", Int J Environ Res Public Health, 14, pp.605~ (2017)
  21. Wang Z, "Difficulties in eliminating measles and controlling rubella and mumps : a cross-sectional study of a first measles and rubella vaccination and a second measles, mumps, and rubella vaccination", PLoS One, 9, pp.e89361~ (2014)
  22. Xiong Y, "Age-related changes in serological susceptibility patterns to measles : results from a seroepidemiological study in Dongguan, China", Hum Vaccin Immunother, 10, pp.1097~1003 (2014)
  23. Yu X, "Analysis of the cause of increased measles incidence in Xinjiang, China in 2004", Pediatr Infect Dis J, 26, pp.513~518 (2007)
  24. Zhang DL, "A hospital-associated measles outbreak among individuals not targeted for vaccination in eastern China, 2014", Vaccine, 33, pp.4100~4104 (2015)
  25. Zhang X, "Duration of maternally derived antibody against measles : a seroepidemiological study of infants aged under 8 months in Qinghai, China", Vaccine, 30, pp.752~757 (2012)
  26. Zhang Z, "Seroepidemiology of measles in Beijing, China : a cross-sectional study", Hum Vaccin Immunother, 15, pp.2112~2116 (2019)
  27. Shin L, "The association between seropositivity and self-reported history of varicella and measles : can we rely on self-reported history?", Am J Infect Control, 46, pp.S11~S12 (2018)
  28. National measles seroprevalence report, "Korea Centers for Disease Control and Prevention", Korea Centers for Disease Control and Prevention, ~ (2001)
  29. Centers for Disease Control and Prevention (CDC), "Elimination of measles--South Korea, 2001–2006", MMWR Morb Mortal Wkly Rep, 56, pp.304~307 (2007)
  30. Measles, mumps, hepatitis B seroprevalence report, "Korea Centers for Disease Control and Prevention", Korea Centers for Disease Control and Prevention, ~ (2007)
  31. Final report of national serological survey for measles, "Korea Centers for Disease Control and Prevention", Korea Centers for Disease Control and Prevention, ~ (2008)
  32. Pang SJ, "The change of IgG antibody titer to measles, mumps and rubella according to age", Korean J Pediatr Infect Dis, 18, pp.117~123 (2011)
  33. Kim YJ, "Seroprevalence of measles-specific IgG antibodies in Korean children", J Clin Virol, 70, pp.S56~ (2015)
  34. Bae GR, "Seroprevalence of measles antibody and its attributable factors in elementary students of routine 2-dose schedule era with vaccination record", J Prev Med Public Health, 38, pp.431~436 (2005)
  35. Chang HH, "Preliminary report of seroprevalence of anti-measles immunoglobulin G among healthcare workers of 6 teaching hospitals of Daegu, Korea in 2019", Infect Chemother, 51, pp.54~57 (2019)
  36. Cho HK, "Seroprevalences of specific IgG antibodies to measles, mumps, and rubella in Korean infants", J Korean Med Sci, 31, pp.1957~1962 (2016)
  37. Jung J, "Seroprevalence of measles in healthcare workers in South Korea", Infect Chemother, 51, pp.58~61 (2019)
  38. Kang HJ, "An increasing, potentially measles-susceptible population over time after vaccination in Korea", Vaccine, 35, pp.4126~4132 (2017)
  39. Kim ES, "Seroprevalence of measles among children affected by national measles elimination program in Korea, 2010", Vaccine, 30, pp.3355~3359 (2012)
  40. Kim SS, "Sero-epidemiology of measles and mumps in Korea : impact of the catch-up campaign on measles immunity", Vaccine, 23, pp.290~297 (2004)
  41. Watanabe T, "Seroprevalence of measles, rubella, mumps, and varicella among health care workers in Japan", Antimicrob Resist Infect Control, 2(Suppl 1), pp.P280~ (2013)
  42. Asari S, "Seroprevalence survey of measles, rubella, varicella, and mumps antibodies in health care workers and evaluation of a vaccination program in a tertiary care hospital in Japan", Am J Infect Control, 31, pp.157~162 (2003)
  43. Hatakeyama S, "Prevalence of measles, rubella, mumps, and varicella antibodies among healthcare workers in Japan", Infect Control Hosp Epidemiol, 25, pp.591~594 (2004)
  44. Kanamori H, "Prevaccination antibody screening and immunization program for healthcare personnel against measles, mumps, rubella, and varicella in a Japanese tertiary care hospital", Tohoku J Exp Med, 234, pp.111~116 (2014)
  45. Kanda E, "Low titers of measles antibodies in Japanese pregnant women : a single-center study", J Obstet Gynaecol Res, 39, pp.500~503 (2013)
  46. Katsuyama M, "Immune status of representative infectious diseases among Japanese female university students", Int J Adolesc Med Health, 30, pp.20160038~ (2018)
  47. Kimura T, "Seroprevalence of measles-and mumps-specific immunoglobulin G among Japanese healthcare students increased during 2007-2012", Jpn J Infect Dis, 66, pp.411~415 (2013)
  48. Kumakura S, "Seroprevalence survey on measles, mumps, rubella and varicella antibodies in healthcare workers in Japan : sex, age, occupational-related differences and vaccine efficacy", Epidemiol Infect, 142, pp.12~19 (2014)
  49. Nishiura C, "Screening for measles vaccination in young Japanese non-healthcare workers through self-reported history", J Occup Health, 54, pp.154~157 (2012)
  50. Shibata H, "Comparative analysis of a complement fixation assay and enzyme immunoassay to determine the seroprevalence of measles and varicella in a survey of healthcare workers", J Int Med Res, 41, pp.224~230 (2013)
  51. Shoho Y, "Vaccination status and antibody titers against rubella and measles among Japanese female college students majoring in childcare between 2015 and 2018", Tohoku J Exp Med, 246, pp.73~79 (2018)
  52. Takemoto K, "Time-series analysis comparing the prevalence of antibodies against nine viral species found in umbilical cord blood in Japan", Jpn J Infect Dis, 69, pp.314~318 (2016)
  53. Tsuji A, "Seroepidemiological study on prevalence of measles antibodies in Urawa City", Keio J Med, 47, pp.209~211 (1998)
  54. Andrews N, "Towards elimination : measles susceptibility in Australia and 17 European countries", Bull World Health Organ, 86, pp.197~204 (2008)
  55. Causer J, "Serological survey of measles and rubella immunity in Sydney preschool children", J Paediatr Child Health, 36, pp.418~421 (2000)
  56. Ferson MJ, "Measles immunity and immunization status in under-5-year-old children in New South Wales : a population-based study", J Paediatr Child Health, 34, pp.339~341 (1998)
  57. Gidding HF, "Declining measles antibodies in the era of elimination : Australia’s experience", Vaccine, 36, pp.507~513 (2018)
  58. Gidding HF, "Sustained measles elimination in Australia and priorities for long term maintenance", Vaccine, 25, pp.3574~3580 (2007)
  59. Gilbert GL, "Impact of the Australian measles control campaign on immunity to measles and rubella", Epidemiol Infect, 127, pp.297~303 (2001)
  60. Hogg GG, "Measles immunity and immunisation status in Australian children 1 to 4 years of age", J Paediatr Child Health, 42, pp.165~169 (2006)
  61. Kelly H, "A random cluster survey and a convenience sample give comparable estimates of immunity to vaccine preventable diseases in children of school age in Victoria, Australia", Vaccine, 20, pp.3130~3136 (2002)
  62. Kelly HA, "Residual susceptibility to measles among young adults in Victoria, Australia following a national targeted measles-mumps-rubella vaccination campaign", BMC Public Health, 7, pp.99~ (2007)
  63. Paxton GA, "East African immigrant children in Australia have poor immunisation coverage", J Paediatr Child Health, 47, pp.888~892 (2011)
  64. Riddell MA, "A serosurvey evaluation of the school-based measles ‘catch-up’ immunisation campaign in Victorian school-aged children", Aust N Z J Public Health, 25, pp.529~533 (2001)
  65. Ang LW, "Prevalence of antibodies against measles, mumps and rubella in the childhood population in Singapore, 2008-2010", Epidemiol Infect, 141, pp.1721~1730 (2013)
  66. Ho HJ, "Progress towards measles elimination in Singapore", Vaccine, 32, pp.6927~6933 (2014)
  67. Ong G, "A 24-year review on the epidemiology and control of measles in Singapore, 1981–2004", Southeast Asian J Trop Med Public Health, 37, pp.96~101 (2006)
  68. Tan AL, "Is measles IgG testing for healthcare providers cost-effective? Results from seroprevalence studies of healthcare providers in a tertiary public hospital with a large foreign-born workforce", Infect Control Hosp Epidemiol, 36, pp.1468~1471 (2015)
  69. Hachiya M, "Evaluation of nationwide supplementary immunization in Lao People’s Democratic Republic : population-based seroprevalence survey of anti-measles and anti-rubella IgG in children and adults, mathematical modelling and a stability testing of the vaccine", PLoS One, 13, pp.e0194931~ (2018)
  70. Phengxay M, "Seroprevalence of rubella and measles antibodies in Lao PDR", Clin Lab, 57, pp.237~244 (2011)
  71. National serosurvey of vaccine preventable diseases, "Weir R", Ministry of Health, ~ (2009)
  72. Williamson D, "Seroprevalence of measles antibodies among high-risk healthcare workers in Auckland, New Zealand : additional justification for assumption of age-determined immunity based on local data", Infect Control Hosp Epidemiol, 31, pp.1082~1084 (2010)
  73. Mahamud A, "Seroprevalence of measles, mumps and rubella among children in American Samoa, 2011, and progress towards West Pacific Region goals of elimination", Vaccine, 31, pp.3683~3687 (2013)
  74. Mao B, "Immunity to polio, measles and rubella in women of child-bearing age and estimated congenital rubella syndrome incidence, Cambodia, 2012", Epidemiol Infect, 143, pp.1858~1867 (2015)
  75. Chuang SK, "Mass measles immunization campaign : experience in the Hong Kong Special Administrative Region of China", Bull World Health Organ, 80, pp.585~591 (2002)
  76. Stambos V, "Low immunity to measles and rubella among female guest workers, northern Mariana Islands", Emerg Infect Dis, 15, pp.1872~1874 (2009)
  77. LeBaron CW, "Persistence of measles antibodies after 2 doses of measles vaccine in a postelimination environment", Arch Pediatr Adolesc Med, 161, pp.294~301 (2007)
  78. Bianchi FP, "Long-term immunogenicity of measles vaccine : an italian retrospective cohort study", J Infect Dis, 221, pp.721~728 (2020)
  79. Durrheim DN, "Accelerating measles elimination in the Western Pacific Region during the calm between the storms", Lancet Reg Health West Pac, 23, pp.100495~ (2022)
  80. Choe YJ, "Measles elimination activities in the western pacific region : experience from the Republic of Korea", J Korean Med Sci, 30(Suppl 2), pp.S115~S121 (2015)
  81. Ward BJ, "Cellular immunity in measles vaccine failure : demonstration of measles antigen-specific lymphoproliferative responses despite limited serum antibody production after revaccination", J Infect Dis, 172, pp.1591~1595 (1995)

관련 논문AI추천

Measles susceptibility of marriage migrant women in Korea강승지, 권순석, 박경화, 신민호, 정숙인, Choi Seong Ryeong, Hanbich Hong1, Kim Sooyeon, Kim Sun A, Na Hae-Young, Shin Sung Un한국역학회 · Epidemiology and Health2022 · 제44권 Seroprevalence of Measles IgG Antibodies in Married Immigrant Women from Multicultural Families in Korea이성근, 이우주, Bahk Young Yil, Go Eunbyeul, Jeon Ji-Yoon, Kim Tong-Soo, Kwon Yerim, Lee Yerin, Lim Hyun-Cheol, Shin MI Yeong대한감염학회 · Infection and Chemotherapy2023 · 제55권 제3호Seroprevalence of Measles in Healthcare Workers in South Korea곽선희, 김선경, 김성한, 정지원, 홍민지대한감염학회 · Infection and Chemotherapy2019 · 제51권 제1호예방접종력이 있는 초등학생의 홍역 항체 양성률 및 기여 요인고운영, 김영택, 배근량, 양병국, 이종구, 임현술대한예방의학회 · 예방의학회지2005 · 제38권 제4호Causes of a Low Measles Seroprevalence among Young Healthcare Workers in Korea정혜민, Choi Sang-Ho, Chong Yong Pil, Cho Sung-Kwan, Joo Jiyeon, Jung Jiwon, Kim Eun Ok, Kim Min Jae, Kim Sung-Han, Kim Sun-Kyung, Kim Yang Soo, Lee Sang-Oh대한감염학회 · Infection and Chemotherapy2023 · 제55권 제3호Epidemic characteristics of measles and efforts to control measles infections in Zhejiang Province, ChinaChen Can, Deng Xuan, Du Yuxia, Feng Yan, He Hanqing, Kexin Cao, Tang Xuewen, Yang Mengya, Yang Shigui, Yan Rui, Zhou Yang, Zhu Yao한국역학회 · Epidemiology and Health2024 · 제46권

이 간행물의 다른 논문 (17건)

Efficacy and Safety of COVID-19 Vaccines in Adolescents: Systematic Review of Randomized Controlled Studies and Observational StudiesKim Jimin, Yun Ki Wook, 최윤영, 최재홍, 최영준, 최미영, Choi Soo-Han, Yu Su-Yeonpp. 12-24Incidence of Dental Discoloration After Tetracycline Exposure in Korean Children: A Nationwide Population-Based StudyKim MinYoung, Kang Chung-Min, Jung Inkyung, Lee Ji Young, Kang Ji-Man, Baek Jee Yeon, Ahn Jong Gyun, Kim Eun Hwa, Lee Myeongjee, Shin Jehee, Lim Sung Minpp. 25-36Clinical Features and Associated Factors of Macrolide-Unresponsive Mycoplasma pneumonia and Efficacy Comparison Between Doxycycline, Tosufloxacin and Corticostreoid as a Second-Line TreatmentAhn Youngmin, Kang Han Byeol, Eun Byung Wook, Park Seungmanpp. 37-45Etiology of Bacteremia in Children With Hemato-Oncologic Diseases From 2013 to 2023: A Single Center StudyChoi Hyoung Soo, Park Sun Woo, Park Ji Young, Lee Hyunjupp. 46-54Effectiveness of Two-dose Varicella Vaccination: Bayesian Network Meta-analysisKim Yun-Kyung, Hong Kwan, Yoon Yoonsun, 이영화, Choe Young Junepp. 55-63
원문 보기